45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
15,441
Insurances with rates
8
CPT / HCPCS codes
13,693
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| Q2043 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $365,410 | $219,246 | — | — | 10 |
| J9347 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $205,901 | $123,541 | — | — | 10 |
| C9293 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $205,870 | $123,522 | — | — | 10 |
| J2351 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN | $205,378 | $123,227 | — | — | 10 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $176,656 | $105,994 | — | — | 10 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $134,076 | $80,445 | — | — | 10 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $113,967 | $68,380 | — | — | 10 |
| C1823 | HB XPER-ZOLL GENERATOR & STIMULATOR LEADS REMEDE | $102,790 | $61,674 | — | — | 9 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $102,689 | $61,613 | — | — | 10 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $101,888 | $61,133 | — | — | 10 |
| 93656 | HB COMPRE EP EVAL ABLTJ ATR FIB PULM VEIN ISOLATION | $91,433 | $54,860 | — | — | 10 |
| 33276 | HB INSERTION PHRENIC NERVE STIMULATOR SYSTEM | $90,563 | $54,338 | — | — | 10 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $87,118 | $52,271 | — | — | 10 |
| 33287 | HB RADIANT-RMVL&RPLCMT PHRENIC NRV STIMULATOR PLS GENERATOR | $83,651 | $50,191 | — | — | 10 |
| 0571T | HB INSERT/RPLCMT ICDS W/SUBSTERNAL ELECTRODE | $82,751 | $49,651 | — | — | 10 |
| 33270 | HB INSERT/REPLACE S-ICD W SUBQ LEAD | $81,589 | $48,953 | — | — | 11 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $80,382 | $48,229 | — | — | 10 |
| A9543 | HB RADIANT-YTTRIUMY90IBRITUMOMABTIUXETAN/DOSE TO 40 MCI | $78,248 | $46,949 | — | — | 10 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $75,220 | $45,132 | — | — | 10 |
| J9026 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $74,625 | $44,775 | — | — | 10 |
| 93654 | HB EP EVAL W/ ABLATION VENTRICULAR TACHYCARDIA | $72,537 | $43,522 | — | — | 10 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $71,435 | $42,861 | — | — | 10 |
| C1768 | HB OR-IMPL PERIPH VASCULAR GRAFT (45) | $71,173 | $42,704 | — | — | 10 |
| 33249 | HB INSRT/REPL DFIB W LEADS SNGL/DUAL CHMB | $69,891 | $41,935 | — | — | 11 |
| 0520T | HB RADIANT CCL-RMVL&RPLCMT PG WCS LV PACG BATTERY COMPNT ONLY | $69,790 | $41,874 | — | — | 10 |
| 0515T | HB RADIANT CCL-INSERTION WRLS CAR STIMULATOR LV PACG COMPL SYS | $69,790 | $41,874 | — | — | 10 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE | $66,538 | $39,923 | — | — | 10 |
| 93653 | HB EP EVAL W/ ABLATION SUPRAVENT ARRHYTHMIA | $63,476 | $38,086 | — | — | 11 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $61,000 | $36,600 | — | — | 10 |
| 33289 | HB TCAT IMPL WRLS P-ART PRS SNR L-T HEMODYN MNTR | $60,510 | $36,306 | — | — | 10 |
| J0896 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $60,185 | $36,111 | — | — | 10 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $58,677 | $35,206 | — | — | 11 |
| 33230 | HB INSERT DFIB PULSE GEN ONLY W EXIST DUAL LEAD | $56,420 | $33,852 | — | — | 10 |
| 33288 | HB RMVL&RPLCMT PHRNC NRV STIM TRNSVNS STIMJ/SNSG LD | $55,659 | $33,395 | — | — | 10 |
| J3055 | TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION | $55,398 | $33,239 | — | — | 10 |
| C2616 | HB BRACHY TX NS SPHERES YT-90 | $54,397 | $32,638 | — | — | 10 |
| C1874 | HB OR-IMPL AORTIC ENDOPROSTH THOR (40) | $53,380 | $32,028 | — | — | 10 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $52,332 | $31,399 | — | — | 10 |
| J1640 | HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION | $52,067 | $31,240 | — | — | 10 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $51,604 | $30,963 | — | — | 10 |
| 93590 | HB RADIANT CCL-PERQ TRANSCATH CLS PARAVALVR LEAK 1 MITRAL VALVE | $51,085 | $30,651 | — | — | 10 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $49,974 | $29,984 | — | — | 10 |
| 93591 | HB PERQ TRANSCATH CLS PARAVALVR LEAK 1 AORTIC VALVE | $49,629 | $29,777 | — | — | 10 |
| C9607 | HB PRQ DRUG ELUDING COR REVASC CHRO ONE VESSEL | $49,234 | $29,540 | — | — | 10 |
| 0823T | HB RADIANT CCL-TCAT INSJ PERM 1CHMBR LDLS PACEMAKER R ATRIAL | $48,717 | $29,230 | — | — | 10 |
| C9606 | HB PRQ DRUG ELUDING COR REVASC W AMI ONE VESSEL | $47,739 | $28,643 | — | — | 9 |
| C9600 | HB RADIANT CCL PRQ DRUG ELUDING COR STENT SINGLE | $47,475 | $28,485 | — | — | 10 |
| 92943 | HB PRQ TRLUML CORONRY CHRONIC OCCLUS REVASC ONE VSL (BARE METAL) | $47,475 | $28,485 | — | — | 10 |
| 93581 | HB PERQ TRNSCATH CLO VENT SEPTAL DEFEC | $47,323 | $28,394 | — | — | 11 |
| C9773 | HB RADIANT CCL-REVASC LITHOTR-STENT TIB/PER | $46,821 | $28,093 | — | — | 10 |
Showing top 50 of 15,441 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.